Compare FRHC & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FRHC | CRL |
|---|---|---|
| Founded | N/A | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 7.5B |
| IPO Year | 1996 | 1999 |
| Metric | FRHC | CRL |
|---|---|---|
| Price | $145.00 | $166.97 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $197.58 |
| AVG Volume (30 Days) | 77.7K | ★ 754.3K |
| Earning Date | 02-09-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $2,050,527,000.00 | $1,857,601,000.00 |
| Revenue This Year | N/A | $0.99 |
| Revenue Next Year | N/A | $3.26 |
| P/E Ratio | $61.23 | ★ N/A |
| Revenue Growth | ★ 25.41 | 10.48 |
| 52 Week Low | $107.98 | $91.86 |
| 52 Week High | $194.01 | $228.88 |
| Indicator | FRHC | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 76.75 | 49.47 |
| Support Level | $130.02 | $146.49 |
| Resistance Level | $178.88 | $182.76 |
| Average True Range (ATR) | 4.76 | 6.68 |
| MACD | 1.12 | 1.56 |
| Stochastic Oscillator | 84.85 | 60.02 |
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.